首页> 外国专利> Prevention and treatment of secondary syndrome of brain nerve cell disorder

Prevention and treatment of secondary syndrome of brain nerve cell disorder

机译:脑神经细胞疾病继发综合征的防治

摘要

PURPOSE:To obtain a preventing and treating agent for after-trouble based on cerebral neurocyte disorder, containing a benzothiazepin derivative as an active ingredient, having improving/protecting action to injury of cerebral neurocyte and having excellent action for preventing necrosis of cerebral neurocyte. CONSTITUTION:A preventing and treating agent containing a benzothiazepin derivative expressed by the formula (R1 to R4 are lower alkyl) or pharmacologically permissible salt, e.g. 2-(4-methoxy-phenyl)-3- acetoxy-5-[2-(dimethylamino)ethyl]-8-chloro-2, 3-dihydro-1, 5-benzothiazepin-4 (5H)-one maleic acid salt as an active ingredient and used as a preventing and treating agent for various aftereffects based on disorder of cerebral neurocyte, e.g. consciousness disorder, motor palsy, allophasis, sensory disturbance, derangement or urinary disturbance. Furthermore, the active ingredient can preferably be administered orally or parenterally in an amount of normally about 0.05-20mg/kg, especially about 0.5-5mg/kg daily.
机译:目的:获得一种基于脑神经细胞疾病的后遗症预防治疗剂,其含有苯并噻唑啉衍生物作为有效成分,对脑神经细胞的损伤具有改善/保护作用,并且在预防脑神经细胞坏死方面具有优异的作用。组成:一种预防和治疗剂,含有式(R 1至R 4为低级烷基)表示的苯并噻唑啉衍生物或药理上允许的盐,例如2-(4-甲氧基-苯基)-3-乙酰氧基-5- [2-(二甲氨基)乙基] -8-氯-2,3-二氢-1,5-苯并噻吩-4-4(5H)-一种马来酸盐作为活性成分,并用作预防和治疗基于脑神经细胞疾病的各种后遗症的药物,例如意识障碍,运动性麻痹,异位症,感觉障碍,精神错乱或泌尿障碍。此外,活性成分优选可以每天通常约0.05-20mg / kg,特别是约0.5-5mg / kg的量口服或胃肠外给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号